COVID-19 epidemic in Germany: what have we learned? - Dr. Jürgen Rockstroh

COVID-19 epidemic in Germany: what have we learned? - Dr. Jürgen Rockstroh

aidsmapCHAT - Thursday 20 August - Professor Jürgen Rockstroh - COVID-19 mortality riskПодробнее

aidsmapCHAT - Thursday 20 August - Professor Jürgen Rockstroh - COVID-19 mortality risk

CAHR2019 - Clinical Sciences PlenaryПодробнее

CAHR2019 - Clinical Sciences Plenary

EACS I Jürgen Rockstroh I 2021Подробнее

EACS I Jürgen Rockstroh I 2021

Con Standpoint | Jürgen Rockstroh, MDПодробнее

Con Standpoint | Jürgen Rockstroh, MD

HCV in 2018 | Jürgen Rockstroh, MDПодробнее

HCV in 2018 | Jürgen Rockstroh, MD

Hepatitis - HIV Co-infection | Jürgen Rockstroh, MDПодробнее

Hepatitis - HIV Co-infection | Jürgen Rockstroh, MD

PRO Standpoint - Jürgen Rockstroh, MDПодробнее

PRO Standpoint - Jürgen Rockstroh, MD

Jürgen Rockstroh - Managing HIV Patients with Limited Treatment Options, German EditionПодробнее

Jürgen Rockstroh - Managing HIV Patients with Limited Treatment Options, German Edition

Lessons to be learned from Germany’s handling of COVID-19Подробнее

Lessons to be learned from Germany’s handling of COVID-19

Two-Drug Regimen - Sharing Experiences / Real World Evidence - Jürgen Rockstroh, MDПодробнее

Two-Drug Regimen - Sharing Experiences / Real World Evidence - Jürgen Rockstroh, MD

HIV/HCV co-infection Jürgen Rockstroh, Bonn, GermanyПодробнее

HIV/HCV co-infection Jürgen Rockstroh, Bonn, Germany

People Living with HIV with Limited Treatment Options - Jürgen Rockstroh, MDПодробнее

People Living with HIV with Limited Treatment Options - Jürgen Rockstroh, MD

COVID-19 in April: What We've LearnedПодробнее

COVID-19 in April: What We've Learned

5 Things in 5 Minutes in Germany​: COVID-19 Reproduction Rate on the RiseПодробнее

5 Things in 5 Minutes in Germany​: COVID-19 Reproduction Rate on the Rise

COVID-19: Lessons Learned in GermanyПодробнее

COVID-19: Lessons Learned in Germany

NETEC: Variants of Concern: Learning from Experiences in the UK and GermanyПодробнее

NETEC: Variants of Concern: Learning from Experiences in the UK and Germany

What We've Learned About COVID-19Подробнее

What We've Learned About COVID-19

What challenges remain in viral hepatitis | Jürgen Rockstroh, MDПодробнее

What challenges remain in viral hepatitis | Jürgen Rockstroh, MD

New hepatitis drugs | Jürgen Rockstroh, MDПодробнее

New hepatitis drugs | Jürgen Rockstroh, MD